Byron J. Hoogwerf
Eli Lilly and Company
166 Papers
1.3K Citations
Byron J. Hoogwerf is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 55, co-authored 164 publications. Previous affiliations of Byron J. Hoogwerf include Cedars-Sinai Medical Center & Calvin College.
Chat about Author
Papers
Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes
TL;DR: Exenatide represents a unique option for adjunctive therapy for patients with type 2 diabetes not achieving adequate glycemic control on oral antidiabetic agents, especially in patients for whom weight gain would be an additional contraindication.
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
TL;DR: In this article, the predictive value of serum triglyceride levels on mortality in post-coronary artery bypass graft (CABG) diabetic patients with subsequent analysis by sex was evaluated.
20
HMG-CoA reductase inhibitors. A new approach to the management of hypercholesterolemia.
TL;DR: Lovastatin is the first HMG-CoA reductase inhibitor commercially available in the United States and its efficacy alone, and in combination with the bile acid sequestrants, is reviewed in this report.
19
Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.
Manjiri Pawaskar,Q. Li,Byron J. Hoogwerf,M. W. Reynolds,Douglas E. Faries,William Engelman,D. Bruhn,R. Bergenstal +7 more
TL;DR: The clinical effectiveness of exenatide BID (exen atide) vs. insulin glargine (glargine) in patients with type 2 diabetes mellitus in ambulatory clinical practice was evaluated.
19
Coronary Artery Bypass Graft Surgery and Cognitive Performance
Gilles Dupuis,E. Kennedy,Ruth Lindquist,Franca B. Barton,Michael L. Terrin,Byron J. Hoogwerf,Susan M. Czajkowski,J.Alan Herd +7 more
TL;DR: On average, cognitive performance improved rather than declined after coronary artery bypass graft surgery, and improvements were consistent across sex, age, and education.
18